Evidence map›Paper›PMID 22114305›Full record

ArticleJournal of cell science2011

The Arp2/3 activator WASH regulates α5β1-integrin-mediated invasive migration.

Tobias Zech, Simon D J Calaminus, Patrick Caswell, Heather J Spence, Michael Carnell, Robert H Insall, Jim Norman, Laura M Machesky

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Article
  3. DysregulatedLife science alliance · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Pathogenicity of the MAGE family.Oncology letters · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tobias ZechBeatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK.
Simon D J Calaminus
Patrick Caswell
Heather J Spence
Michael Carnell
Robert H Insall
Jim Norman
Laura M Machesky
Cancer Research UK Scotland Institute · GB

Funding

Cancer Research UK G117/537Cancer Research UK G117/569Medical Research Council G117/537Medical Research Council G117/569
6 · The paper itself

Abstract

The actin cytoskeleton provides scaffolding and physical force to effect fundamental processes such as motility, cytokinesis and vesicle trafficking. The Arp2/3 complex nucleates actin structures and contributes to endocytic vesicle invagination and trafficking away from the plasma membrane. Internalisation and directed recycling of integrins are major driving forces for invasive cell motility and potentially for cancer metastasis. Here, we describe a direct requirement for WASH and Arp2/3-mediated actin polymerisation on the endosomal membrane system for α5β1 integrin recycling. WASH regulates the trafficking of endosomal α5β1 integrin to the plasma membrane and is fundamental for integrin-driven cell morphology changes and integrin-mediated cancer cell invasion. Thus, we implicate WASH and Arp2/3-driven actin nucleation in receptor recycling leading to invasive motility.

Indexed as

Cell MovementActin-Related Protein 2-3 ComplexActinsAnimalsCell Line, TumorCell MembraneEndosomesHumansIntegrin alpha5beta1Neoplasm InvasivenessNeoplasmsProtein TransportWiskott-Aldrich Syndrome ProteinActin-Related Protein 2-3 ComplexActinsIntegrin alpha5beta1Wiskott-Aldrich Syndrome Protein

Identifiers

PMID22114305
PMCPMC3225265
OpenAlexW2129580137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.